… the differences in prostate volume were significantly higher in obese patients, older patients
and in … However, no difference was noted between patients with and those without metabolic …

… patients, whereas in patients with a maximum urinary flow rate of greater than 15 mL/s,
subvesical obstruction is present in only 30%. Of the men in the indeterminate group, with a peak …

… benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms (LUTS) and improving
the maximal urinary flow rate in shortand long-term treatment, regardless of prostate size, …

… Some such symptoms—eg, urinary incontinence—might have a greater effect on quality
of life than others, and could prove especially troublesome for some patients. Men aged …

INTRODUCTION AND OBJECTIVES Prostatic inflammation could be a key component in
prostate enlargement and benign prostatic hyperplasia (BPH) progression. Our aim was to …

… In a recent retrospective study, patients with a positive family history of BPH had prostates
… efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. …

Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS)
commonly affect older men. Age-related changes associated with metabolic disturbances, …

… PAE is a safe and effective treatment for lower urinary tract symptoms secondary to benign
prostatic hyperplasia in patients with prostate volume > 90 g. Excessively elevated prostate-…

… Treatment decisions should be made with patient participation and with patient goals in mind.
Outcomes of medical and surgical procedures, and the occurrence of adverse events must …

… The pathophysiology of benign prostatic hyperplasia remains … histologic features of benign
prostatic hyperplasia is dependent … The patient described in the vignette has benign prostatic …